Metagenomi, Inc. (MGX) Stock Statistics & Valuation Metrics

Metagenomi, Inc. has a market cap or net worth of $65.42M. The enterprise value is -$67.45M.

Metagenomi, Inc. has 37,383,472 shares outstanding. The number of shares has decreased by -2.65% in one year.

Metagenomi, Inc.’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -28.35%.

The current PE Ratio of Metagenomi, Inc. is 0.00. Metagenomi, Inc.’s PEG ratio is 0.00.

In the last 12 months, Metagenomi, Inc. had revenue of 52.30M and earned -78.06M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -109.07M and capital expenditures -3.11M, giving a free cash flow of -112.19M billion.

Metagenomi, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Metagenomi, Inc. upcoming earnings date is May 20, 2025, TBA Not Confirmed.

Metagenomi, Inc. as a current ratio of 6.91, with Debt / Equity ratio of 19.49%

In the past 12 months, Metagenomi, Inc. has paid -5.51M in taxes.

Metagenomi, Inc. EV to EBITDA ratio is -0.22, with an EV/FCF ratio of -0.16.

Metagenomi, Inc. has $248.31M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$202.53M billion.

Gross margin is 95.06%, with operating margin of -170.00%, and net profit margin of -149.26%.

The average price target for Metagenomi, Inc. is $13.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy